News

28 . 05 . 2021

Glow LifeTech Secures Canadian Processing Facility; Begins Build-out to Produce Next-Generation Cannabis Ingredients

Read More
11 . 05 . 2021

Glow LifeTech Reports on Additional Research Results on ArtemiC™ and Positive Implications for COVID-19 Variants

Read More
04 . 05 . 2021

Glow LifeTech Announces Successful First Commercial Production of ArtemiC™ for Global Distributor and a Second Production Scaled to Meet Growing Global Demand

Read More
27 . 04 . 2021

Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial

Read More
12 . 03 . 2021

Glow LifeTech to Commence Trading on the CSE on March 15, 2021 Under the Symbol “GLOW”

Read More
03 . 03 . 2021

Glow LifeTech Corp. Announces Completion of Business Combination

Read More
16 . 02 . 2021

Relay Medical Reports Glow LifeTech Secures Exclusive North American Rights to ArtemiC™ Following Successful COVID-19 Phase II Clinical Trial

Read More
02 . 03 . 2020

Relay Medical Announces Subsidiary Glow LifeTech has Secured Exclusive Rights for Award Winning Swiss Technology

Read More